Salinamide A is a depsipeptide antibiotic that potently inhibits bacterial RNA polymerase by binding to a unique site known as the "bridge-helix cap," thereby preventing critical conformational changes required for nucleotide addition during both transcription initiation and elongation. This targeted mechanism blocks RNA synthesis in cells with high specificity, achieving inhibition of transcription at nanomolar concentrations. Researchers widely use salinamide A as a precise chemical probe to study the role of the bridge-helix N-terminal hinge in RNA polymerase function and conformation.
Marketplace OffersShowing from 1 suppliers1 SUPPLIERS